Evidence-Based Benefits
- Lower back pain — Chrubasik et al. (2000, n=210) found 240mg salicin daily reduced pain scores significantly more than placebo, with efficacy comparable to rofecoxib 12.5mg
- Osteoarthritis — Schmid et al. (2001, n=78) demonstrated willow bark extract (240mg salicin) significantly reduced WOMAC pain scores in hip and knee OA patients over 2 weeks
- COX-2 inhibition — salicylic acid (from salicin metabolism) inhibits COX-2 enzyme activity and expression, reducing prostaglandin E2 production
- GI-sparing mechanism — salicin is not directly irritating to gastric mucosa; it is converted to salicylic acid after absorption, potentially causing less GI damage than aspirin
- Synergistic polyphenols — willow bark contains flavonoids, tannins, and other polyphenols that provide antioxidant and anti-inflammatory effects beyond salicin alone